Posts Tagged ‘fampridine’
">
The drug fampridine slows the progression of Multiple Sclerosis, a disease characterized by the loss of the insulation around nerves.
U. ROCHESTER (US)—A drug that has shown promise treating a debilitating symptom of multiple sclerosis (MS) is one step closer to market. Newly released findings from clinical trials in the United States and Canada show the experimental drug fampridine improves walking ability in some patients.
Neurologist Andrew Goodman, chief of the Multiple Sclerosis Center at the University of Rochester Medical Center and lead author of the study, says that many MS patients experience a decline in mobility and this disability has a major impact in terms of quality of life.
Continue…
